Stanley Druckenmiller just put a massive $1.2 billion on only three healthcare stocks—Natera, Insmed, and Teva. Instead of spreading his chips, he’s all-in on genetic testing, rare disease drugs, and a big pharma comeback. The real drama? He ditched tech darlings like Nvidia to double down on healthcare innovation. If you’re looking for a fresh investing angle, maybe it’s time to peek at your medicine cabinet instead of your phone screen. #Business #Market #investing